Richter O, Klatte A, Abel J, Freye E, Haag W, Hartung E
Int J Clin Pharmacol Ther Toxicol. 1985 Jan;23(1):11-5.
The pharmacokinetics of Alfentanil, a new short acting analgesic, and Etomidate, a very short acting hypnotic compound, were studied in patients undergoing orthopedic surgery. Anesthesia was induced by bolus i.v. injection of Alfentanil and Etomidate, whereas the maintenance was performed by continuous infusion of Etomidate and repetitive i.v. injections of Alfentanil. The kinetics of the analgesic can be described by a two-compartment model; the elimination half-life has a mean value of 64.8 +/- 38.5 min. No cumulation of the drug was seen in spite of multiple injections. Concerning Etomidate it is not clear whether one or two compartments are needed. The mean elimination half-life is 29.4 +/- 6.2 min. The results suggest a possible shortening of the half-life of Etomidate in the presence of Alfentanil.
在接受骨科手术的患者中,对新型短效镇痛药阿芬太尼和超短效催眠化合物依托咪酯的药代动力学进行了研究。通过静脉推注阿芬太尼和依托咪酯诱导麻醉,而维持麻醉则通过持续输注依托咪酯和重复静脉注射阿芬太尼来进行。镇痛药的动力学可用二室模型描述;消除半衰期的平均值为64.8±38.5分钟。尽管多次注射,但未观察到药物蓄积。关于依托咪酯,尚不清楚需要一室模型还是二室模型。平均消除半衰期为29.4±6.2分钟。结果表明,在存在阿芬太尼的情况下,依托咪酯的半衰期可能会缩短。